openPR Logo
Press release

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzheimer Market: Ken Research

09-13-2021 08:56 PM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Global Alzheimer Market, Global Alzheimer Industry, Covid-19

Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is often the cause of this disease.

As per analysis, “Global Alzheimer Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)” the key companies operating in the global Alzheimer market include Daiichi Sankyo, Eisai, Pfizer, Lundbeck, Novartis, Merz Pharma, Allergan, Johnson and Johanson and among others. Key companies are involved in mergers & acquisitions to support their position in the market. Due to increasing competition frequent innovations are often take place in the market.

Based on type, Alzheimer market can be divided as Memantine, Donepezil and Rivastigmine. Memantine is a prescription medicine/remedy used to treat moderate to the severe dementia. Donepezil is belongs to a class of drug called cholinesterase inhibitors. It improves the mental function (such as attention, memory, ability to interact with others, think clearly, speak, and perform regular daily activities) by increasing the amount of a definite naturally occurring substance in the brain. Donepezil may improve thinking and memory, or slow the loss of these abilities in people with Alzheimer's. In addition, based on application type, market can be divided as early to moderate stages and moderate to severe stages.

Growth in healthcare spending per capita, followed by presence of key players, rapid growth in the number of people living with Alzheimer’s disease, increase in government funding for research & development (R&D) and huge patient population are some major factors, which are responsible for growth of the Alzheimer market. Apart from this, high failure rates of clinical studies related to diagnosis & treatment of Alzheimer's is a major hindering factor for market. Moreover, growth in technological advancements in diagnostics & biomarkers is a leading opportunity for market.
Based on regional analysis, the North-America region holds major region in global Alzheimer market owing to rise in demand for advanced therapies & diagnostic tool with modified drugs and high prevalence of disease across the region. However, there have been many reports of neurological complications related to COVID-19.

The COVID-19 pandemic has also revolutionized the daily routines of Alzheimer's patients by adopting social distancing and isolation in the United States. It is understood that many Alzheimer's patients have experienced negative effects on their mental health. Additionally, the Europe and Asia-Pacific regions are anticipated to exhibit substantial growth rate due to rise in awareness regarding early detection of the disease and growth in improvements in healthcare infrastructure over the forecast period. It is predicted that future of the global Alzheimer market will be bright as a result of rise in cases resulting in spreading awareness of early diagnosis of the disease during the forecast period.

For More Information, Click on the Link Below:-
https://www.kenresearch.com/healthcare/pharmaceuticals/alzheimer-market-report/343705-91.html

Related Reports:-
https://www.kenresearch.com/healthcare/medical-devices/alzheimer-s-therapeutics-market/466476-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/alzheimers-disease-patients/455559-91.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
support@kenresearch.com
+91-9015378249

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a research based management consulting company. We provide strategic consultancy to aid clients on critical business perspective: strategy, marketing, organization, operations and technology transformation, advanced analytics, corporate finance, mergers & acquisitions and sustainability across all industries and geographies. We provide business intelligence and operational advisory across 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Some of top consulting companies and Market leaders seek our intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzheimer Market: Ken Research here

News-ID: 2391274 • Views: 270

More Releases from Ken Research Pvt Ltd

Global Monocrystalline Silicon Market is predicted to augment during the Near Fu …
Monocrystalline silicon, more often called single-crystal silicon, is the base material for the silicon-based discrete component and combined circuits utilized in virtually all the advance electronic equipment. Monocrystalline silicon also serves as a photovoltaic, light-absorbing material in the production of solar cells. It comprises of silicon in which the crystal lattice of the whole solid is continuous, free of any grain boundaries and unbroken to its edges. Monocrystalline silicon can
Global Energy Drinks Market, Global Energy Drinks Industry, Covid-19 Impact Glob …
An energy drink is a type of drink comprising stimulant compounds, primarily caffeine, which is promoted as conveying mental and physical stimulation. They may or may not be carbonated and may also comprise, sugar and several other sweeteners, herbal extract, amino acids and taurine. They are a subset of the greater group of the energy products, which comprise gels and bars, and distinct from the sports drinks, which are advertised
Global Obturator Foam Tape Market 2021 Report by Size and Share, Top Company Pro …
Foam tapes are used for permanent or temporary fixing, packaging, soundproofing, thermal insulation, and gap filling. These tapes are generally made of open-cell foams or closed-cell foams, which are covered with different types of pressure-sensitive adhesives (PSAs), and they come in a range of thicknesses. Each foam tape has unique features & ideal purposes. Foam tape is commonly used in the automobile and building & construction sectors. The use of lightweight
Global Spray Unshaped Refractory Market 2021– Top Manufacturers, Latest Trends …
Refractory are characterized as various non-metallic, inorganic, porous and heterogeneous materials, which are designed to endure high industrial temperatures & pressures. Most common types of refractory materials include high alumina minerals, fireclay, silica, chromite, magnesite, etc. They consist of material-resistant materials because they are resistant to mechanical and thermal stress, corrosion from solids, liquids and gases, mechanical abrasion and the diffusion of gases. They are used in kettles and ovens

All 5 Releases


More Releases for Alzheimer

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growt …
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently
Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as